Your browser doesn't support javascript.
loading
Chemoproteomics Enabled Discovery of Selective Probes for NuA4 Factor BRD8.
Remillard, David; Savage, Nikolas A; Kedves, Alexia T; Paulk, Joshiawa; Chen, Xin; Garcia, Francisco J; Romanowski, Michael J; Horton, Patricia A; Murphy, Jason; Schirle, Markus; Harrington, Edmund M; Maxwell, Matthew B; Pham, Helen Trinh; Maksimovic, Igor; Thomas, Jason R; Forrester, William C.
Afiliação
  • Remillard D; Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts 02139, United States.
  • Savage NA; Harvard Program in Therapeutic Science, Harvard Medical School, Boston, Massachusetts 02115, United States.
  • Kedves AT; Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts 02139, United States.
  • Paulk J; Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts 02139, United States.
  • Chen X; Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts 02139, United States.
  • Garcia FJ; Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts 02139, United States.
  • Romanowski MJ; Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts 02139, United States.
  • Horton PA; Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts 02139, United States.
  • Murphy J; Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts 02139, United States.
  • Schirle M; Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts 02139, United States.
  • Harrington EM; Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts 02139, United States.
  • Maxwell MB; Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts 02139, United States.
  • Pham HT; Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts 02139, United States.
  • Maksimovic I; Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts 02139, United States.
  • Thomas JR; Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts 02139, United States.
  • Forrester WC; Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts 02139, United States.
ACS Chem Biol ; 16(11): 2185-2192, 2021 11 19.
Article em En | MEDLINE | ID: mdl-34515462
ABSTRACT
Bromodomain-containing proteins frequently reside in multisubunit chromatin complexes with tissue or cell state-specific compositions. Recent studies have revealed tumor-specific dependencies on the BAF complex bromodomain subunit BRD9 that are a result of recurrent mutations afflicting the structure and composition of associated complex members. To enable the study of ligand engaged complex assemblies, we established a chemoproteomics approach using a functionalized derivative of the BRD9 ligand BI-9564 as an affinity matrix. Unexpectedly, in addition to known interactions with BRD9 and associated BAF complex proteins, we identify a previously unreported interaction with members of the NuA4 complex through the bromodomain-containing subunit BRD8. We apply this finding, alongside a homology-model-guided design, to develop chemical biology approaches for the study of BRD8 inhibition and to arrive at first-in-class selective and cellularly active probes for BRD8. These tools will empower further pharmacological studies of BRD9 and BRD8 within respective BAF and NuA4 complexes.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Benzilaminas / Proteômica / Naftiridinas Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Benzilaminas / Proteômica / Naftiridinas Idioma: En Ano de publicação: 2021 Tipo de documento: Article